Table 1.
Clinical Characteristics of Patient Cohort.
| Grade | n | Median Age (Years) | Recurrence Rates | Median Overall Survival (Months) | Gender (% of Cases) | IDH1 Status (% of Cases) | Main Lobe Localization (% of Cases) | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Pilocytic | 39 | 6 | 43% | 94 | Male | 59 | Wild-type | 100 | Frontal | 3 |
| Temporal | 5 | |||||||||
| Parietal | 3 | |||||||||
| Occipital | 0 | |||||||||
| Female | 41 | R132H | 0 | More than one lobe | 8 | |||||
| Cerebellar | 51 | |||||||||
| Other | 30 | |||||||||
| Diffuse | 49 | 35 | 64% | 66.5 | Male | 53 | Wild-type | 33 | Frontal | 40 |
| Temporal | 29 | |||||||||
| Parietal | 2 | |||||||||
| Occipital | 0 | |||||||||
| Female | 47 | R132H | 67 | More than one lobe | 16 | |||||
| Cerebellar | 2 | |||||||||
| Other | 11 | |||||||||
| Anaplastic | 16 | 35 | 67% | 38.8 | Male | 50 | Wild-type | 15 | Frontal | 60 |
| Temporal | 20 | |||||||||
| Parietal | 0 | |||||||||
| Occipital | 0 | |||||||||
| Female | 50 | R132H | 85 | More than one lobe | 7 | |||||
| Cerebellar | 13 | |||||||||
| Other | 0 | |||||||||
| Glioblastoma | 95 | 54 | 92% | 10.2 | Male | 58 | Wild-type | 85 | Frontal | 32 |
| Temporal | 30 | |||||||||
| Parietal | 3 | |||||||||
| Occipital | 2 | |||||||||
| Female | 42 | R132H | 15 | More than one lobe | 29 | |||||
| Cerebellar | 1 | |||||||||
| Other | 2 | |||||||||